iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Sees Large Decrease in Short Interest

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large decline in short interest in February. As of February 27th, there was short interest totaling 2,917 shares, a decline of 39.3% from the February 12th total of 4,809 shares. Based on an average trading volume of 969 shares, the short-interest ratio is currently 3.0 days. Approximately 1.9% of the company’s stock are sold short. Approximately 1.9% of the company’s stock are sold short. Based on an average trading volume of 969 shares, the short-interest ratio is currently 3.0 days.

iShares Neuroscience and Healthcare ETF Stock Performance

Shares of NYSEARCA:IBRN traded down $0.55 during midday trading on Friday, hitting $31.00. 5,302 shares of the stock were exchanged, compared to its average volume of 2,139. iShares Neuroscience and Healthcare ETF has a 52-week low of $17.86 and a 52-week high of $37.00. The business’s fifty day simple moving average is $32.20 and its two-hundred day simple moving average is $30.12. The company has a market capitalization of $4.65 million, a PE ratio of 15.61 and a beta of 0.93.

iShares Neuroscience and Healthcare ETF Company Profile

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.